A phase II trial of a prostaglandin D2 receptor antagonist for the treatment of asthma.
Latest Information Update: 01 Aug 2012
At a glance
- Drugs Prostaglandin D2 receptor antagonist Actelion (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 01 Aug 2012 New trial record